In triple-negative breast cancer, XBP1 has been reported to be a pivotal role in the tumorigenicity and progression and XBP1 gene expression was highly associated with HIF1α and hypoxia-driven signatures (18). The gene discussed is HIF1A; the disease is triple-negative breast carcinoma.